Metastatic Breast Cancer Clinical Trials

There are 16 registered clinical trials for Metastatic Breast Cancer in the TrialLens index.

Trials (16)

• S 81694 Plus Paclitaxel in Metastatic Breast Cancer Phase 1/2 · Institut de Recherches Internationales Servier
• Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes Phase 2 · Centre Jean Perrin
• Definitive Radiation for High-Risk Spine Metastases Phase 2 · Stony Brook University
• BRaziLian outcomE for metAStatic breasT Cancer N/A · Hospital do Coracao
• ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer Phase 1 · Ono Pharmaceutical Co., Ltd.
• ER Reactivation Therapy for Breast Cancer Phase 2 · Dartmouth-Hitchcock Medical Center
• Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer Phase 2 · Hoosier Cancer Research Network
• To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older Phase 3 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
• Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) N/A · University of California, San Francisco
• B002 in Patients With HER2-positive Breast Cancer Phase 1 · Shanghai Pharmaceuticals Holding Co., Ltd
• Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients Phase 1/2 · Weill Medical College of Cornell University
• Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer Phase 2 · Saint Luke's Health System
• Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer Phase 2 · Asan Medical Center
• Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer N/A · Ain Shams University
• Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer Phase 2 · University of California, Irvine
• Fulvestrant + Neratinib In Breast Cancer Phase 2 · Massachusetts General Hospital

Related landscapes

• Phase 1/2 Metastatic Breast Cancer
• Phase 2 Metastatic Breast Cancer
• Phase 3 Metastatic Breast Cancer
• N/A Metastatic Breast Cancer
• Phase 1 Metastatic Breast Cancer

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.